Skip to Content
Merck
Search Within
Document Type

471-34-1

Applied Filters:
Keyword:'471-34-1'
Showing 1-30 of 44 results for "471-34-1" within Technical Documents
Quality Control Range Sheet- HCVM3-110 and HCVM3-210
Control 1 7.0 - 15 ng/mL Control 1 86 – 179 ng/mL Control 2 69 - 144 ng/mL Control 2 471 – 979
Product Information Sheet - C3174
Store at Room Temperature 25,650-1 is an exact replacement for C 3174 Product Description Molecular Formula: CaCO3 Molecular Weight: 100.1 CAS Number: 471-34-1 Synonym: calcite This product
Product Information Sheet - C6033
6033 Product Description Molecular Formula: CaCO3 Molecular Weight: 100.1 CAS Number: 471-34-1 Synonym: calcite This product is designated as ACS Reagent grade and meets the specifications
Data Sheet - P2368
- activating-factor-I as a protein phosphatase 2A inhibitor. Biochem. Biophys. Res. Commun., 259, 471-475 (1999). 4. Okuwaki, M., and Nagata, K., Template activating factor-I remodels the chromatin
Product Information Sheet - C3049
Store at Room Temperature 39,810-1 is an exact replacement for C 3049 Product Description Molecular Formula: CaCO3 Molecular Weight: 100.1 CAS Number: 471-34-1 Synonym: calcite This product
Product Information Sheet - I1149
J. Biochem., 63, 175, 1976. 19. Sumbilla, C. and Waechter, C.J., Methods Enzymol., 111, 471, 1985. 20. Broom, M.F. et al., Biochem. J., 257, 51, 1989. 21. Medonca, M.H. and Zancan, G.T.
Product Information Sheet - I6125
J. Biochem., 63, 175, 1976. 19. Sumbilla, C. and Waechter, C.J., Methods Enzymol., 111, 471, 1985. 20. Broom, M.F. et al., Biochem. J., 257, 51, 1989. 21. Medonca, M.H. and Zancan, G.T.
XP725 Antibody Number-Lot Number 071M4826
e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h 1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76 1.2 5 6 7 8 29 30 31 32 53 54 55 56
Books Listing
Product Description Quantity G 8416 Gene Transfer Methods: Introducing 1 each DNA into Living Cells and Organisms ISBN 1-881299-34-1 Gene Transfer Methods: Introducing DNA into Living Cells and Organisms
Novabiochem Letters 02/06
Tetrahedron Lett., 34, 1549. 7. A. Trzeciak & W. Bannwarth (1992) Tetrahedron Lett., 33, 4557. 8. C. Flouzat, et al. (1997) Tetrahedron Lett., 38, 1191. 9. J. S. Davies (2003) J. Pept. Sci., 9, 471. 10. B. Rohwedder
Datasheet - M4439
p64/66c-myc protein.1 Nevertheless, weak reaction with murine c-myc may be seen when the antibody is used at high concentration. Several theses9-14 and dissertations15-34 cite use of this M4439
Product Information Sheet - M4439
p64/66c-myc protein.1 Nevertheless, weak reaction with murine c-myc may be seen when the antibody is used at high concentration. Several theses9-14 and dissertations15-34 cite use of this M4439
Building blocks for peptide synthesis
Res., 34, 287. 35. P. Rovero, et al. (1993) Tetrahedron. Lett., 34, 2199. 36. G. Barany & R.B. Merrifield in “Peptides 2”, E. Gross & J. Meienhofer (Eds.); Academic Press, New York, 1980, pp. 1.
Salts for analysis
Calcium carbonate precipitated for analysis EMSURE® Reag. Ph Eur 471-34-1 CaCO 3 100.09 g/mol 250 g Plastic bottle 1.02066.0250 1 kg Plastic bottle 1.02066.1000 50 kg Fibre carton 1.02066.9050
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
Chromosome Res., 2, 471-473 (1994). 7. Chang, C.P., et al., Neuron, 11, 1187-1195 (1993). 8. Perrin, M.H., et al., Endocrinology, 133, 3058-3061 (1993). 9. Vita, N., et al., FEBS Lett., 335, 1-5 (1993). 10.
LIGHT DIAGNOSTICS™ ECHOVIRUS 30 MONOCLONAL ANTIBODY
echo 1, echo 2, echo 3, echo 4, echo 5, echo 6, echo 7, echo 9, echo 11, echo 11', echo 13, echo 14, echo 15, echo 16, echo 18, echo 20, echo 21, echo 22, echo 25, echo 29
Article: Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis
Kramer, et al., Trends in 30-day and 1-year mortality among patients hospitalized with cirrhosis from 2004 to 2013, Am. J. Gastroenterol. 112 (2017) 1287–1297. [34] W. Zhao, Z. Wu, Y. Li, et al., Pretreatment
Research Focus - Volume 2, 2013
inhibitor of GSK-3β (IC50 = 34, 67 and 304 nM in the presence of 10, 30 and 100 µM ATP, respectively). 10 mg GSK-3β Inhibitor XXIV (2-Methyl- 5-(3-[4-(methylsulfinyl) phenyl)-1- benzofuran-5-yl)-1,3,4
Tools and Tips for Analyzing Apoptosis: A Kit Selection Guide
364 .3 1 mg 5 mg €100 €353 Genistein 345834 270 .2 20 mg 50 mg €87 €173 [6]-Gingerol, Zingiber officinale 345868 294 .4 5 mg €153 Glycodeoxycholic Acid, Sodium Salt 361311 471 .6 5 g
Tools and Tips for Analyzing Apoptosis
Japan 371955 364 .3 1 mg 5 mg Genistein 345834 270 .2 20 mg 50 mg [6]-Gingerol, Zingiber officinale 345868 294 .4 5 mg Glycodeoxycholic Acid, Sodium Salt 361311 471 .6 5 g
Perfection in every dimension - Inorganic Reagents catalog
Packaging Ord. No. Marble granular for producing CO2 471-34-1 1 kg Plastic bottle 1.05986.1000 Marble granular for producing CO2 471-34-1 5 kg Plastic bottle 1.05986.5000 Application advice Marble
Empower your Lab
Eur 471-34-1 CaCO3 250 g HDPE bottle 1.02066.0250 1 kg HDPE bottle 1.02066.1000 50 kg Fibre carton 1.02066.9050 Calcium carbonate precipitated for analysis of silicates EMSURE® 471-34-1 CaCO3
Inorganics & Solvents for classical analysis
Eur 471-34-1 CaCO3 250 g HDPE bottle 1.02066.0250 1 kg HDPE bottle 1.02066.1000 50 kg Fibre carton 1.02066.9050 Calcium carbonate precipitated for analysis of silicates EMSURE® 471-34-1 CaCO3
Apoptosis - Antibodies, Reagents and Kits
Anti-DAP Kinase 2 H M R WB Rb 100 µg AB3606 $220 Daxx Anti-Daxx H M R Ht WB IP IC Rb IgG 200 µL 07-471 $299 Anti-Daxx, C-terminus H WB Rb 100 µg AB16959
Stem Cell Research
Pluripotent Stem Cells pages 16-24 Neural Stem Cells pages 25-34 Mesenchymal Stem Cells pages 35-40 General Cell Culture pages 41-42 1 2 3 4 5
XP725 Antibody List Lot 129K4831
004751.2 y y y 311 GRP1 G6541 9265 CYTH3 M NP_004218.1 y n/d y 34 ARNO (Cytohesin-2) A4721 9266 CYTH2 M NP_004219.3 y n/d y 202 Cytohesin-1 C8979 9267 CYTH1 M NP_004753.1 y n/d n/d 626 Rab9 R5404 9367 RAB9A
XP725 Antibody List Lot 129K4830
004751.2 y y y 311 GRP1 G6541 9265 CYTH3 M NP_004218.1 y n/d y 34 ARNO (Cytohesin-2) A4721 9266 CYTH2 M NP_004219.3 y n/d y 202 Cytohesin-1 C8979 9267 CYTH1 M NP_004753.1 y n/d n/d 626 Rab9 R5404 9367 RAB9A
XP725 Antibody List Lot 089K4791
004751.2 y y y 311 GRP1 G6541 9265 CYTH3 M NP_004218.1 y n/d y 34 ARNO (Cytohesin-2) A4721 9266 CYTH2 M NP_004219.3 y n/d y 202 Cytohesin-1 C8979 9267 CYTH1 M NP_004753.1 y n/d n/d 626 Rab9 R5404 9367 RAB9A
Millipore's 2008 Sustainability Report
behaviors the employee should enhance. Training, individual development, and other factors led to 471 employee promotions in 2008, 533 in 2007, and 470 in 2006. In 2008, employees participated
List of Antibodies
464 MSK-1 M5437 P y n/d y 465 MTA 2 M7569 M y y y 466 MTA1 M1320 M y y y 467 MTA1 M7693 P y n/d n/d 468 MTA2/MTA1L M7818 P y n/d n/d 469 MTA3L M0819 P y n/d n/d 470 MTBP M3566
Page 1 of 2